MX2018011334A - Composiciones y su uso. - Google Patents
Composiciones y su uso.Info
- Publication number
- MX2018011334A MX2018011334A MX2018011334A MX2018011334A MX2018011334A MX 2018011334 A MX2018011334 A MX 2018011334A MX 2018011334 A MX2018011334 A MX 2018011334A MX 2018011334 A MX2018011334 A MX 2018011334A MX 2018011334 A MX2018011334 A MX 2018011334A
- Authority
- MX
- Mexico
- Prior art keywords
- potential
- composition
- female subject
- cognitive
- brain
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000004556 brain Anatomy 0.000 abstract 2
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 230000023105 myelination Effects 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición que comprende al menos una vitamina, para usar en la promoción, apoyo u optimización de uno o más de los siguientes: (i) mielinización de novo; (ii) estructura del cerebro; (iii) conectividad del cerebro; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizaje; y (vii) función cognitiva en una cría de un sujeto femenino, en donde la composición es para la administración al sujeto femenino.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315158P | 2016-03-30 | 2016-03-30 | |
| US201662315163P | 2016-03-30 | 2016-03-30 | |
| US201662315142P | 2016-03-30 | 2016-03-30 | |
| US201662315134P | 2016-03-30 | 2016-03-30 | |
| US201662315152P | 2016-03-30 | 2016-03-30 | |
| US201662328119P | 2016-04-27 | 2016-04-27 | |
| PCT/EP2016/080796 WO2017167420A1 (en) | 2016-03-30 | 2016-12-13 | Compositions comprising vitamins and their use |
| PCT/EP2017/057575 WO2017167898A2 (en) | 2016-03-30 | 2017-03-30 | Compositions and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018011334A true MX2018011334A (es) | 2019-01-31 |
Family
ID=57614348
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008519A MX2018008519A (es) | 2016-03-30 | 2016-12-13 | Composiciones que comprenden vitaminas y su uso. |
| MX2018011334A MX2018011334A (es) | 2016-03-30 | 2017-03-30 | Composiciones y su uso. |
| MX2022014682A MX2022014682A (es) | 2016-03-30 | 2018-09-18 | Composiciones y su uso. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008519A MX2018008519A (es) | 2016-03-30 | 2016-12-13 | Composiciones que comprenden vitaminas y su uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022014682A MX2022014682A (es) | 2016-03-30 | 2018-09-18 | Composiciones y su uso. |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP3436015A2 (es) |
| CN (4) | CN108367009A (es) |
| BR (2) | BR112018011404A2 (es) |
| CA (3) | CA3004046A1 (es) |
| MX (3) | MX2018008519A (es) |
| PH (1) | PH12018501830A1 (es) |
| SG (2) | SG11201803025VA (es) |
| WO (1) | WO2017167420A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110157711B (zh) * | 2019-02-01 | 2023-10-24 | 大连大学 | 一种人的srebp1基因编码区全长分段克隆的方法 |
| AU2021317083A1 (en) * | 2020-07-27 | 2023-03-02 | George AYOUB | Methods of reducing incidence or risk of cerebral folate deficiency |
| IT202100022427A1 (it) * | 2021-08-27 | 2023-02-27 | Buona S P A Soc Benefit | Composizione per la maturazione del sistema nervoso centrale |
| EP4572618A1 (en) | 2022-08-18 | 2025-06-25 | Société des Produits Nestlé S.A. | Kit to promote developmental myelination |
| CN116195643A (zh) * | 2022-12-20 | 2023-06-02 | 安徽九鑫药业有限公司 | 一种补脑的核桃油乳粉制剂 |
| WO2025143715A1 (ko) * | 2023-12-26 | 2025-07-03 | 주식회사 비케이바이오 | 인지질 혼합물, 중성지질 및 스핀고리피드를 포함하는 인지기능 개선 조성물 |
| WO2025252789A1 (en) | 2024-06-04 | 2025-12-11 | Société des Produits Nestlé S.A. | Nutritional composition linked to brain myelination, brain structure, cognition and learning in typically developing school age children |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0322589B1 (fr) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
| EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
| WO1999063943A2 (en) * | 1998-06-12 | 1999-12-16 | Craig Anthony Cooney | Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring |
| RU2275041C2 (ru) | 1999-04-29 | 2006-04-27 | Сосьете Де Продюи Нестле С.А. | Состав молочной смеси, способ его получения и молочная смесь, содержащая его (варианты) |
| KR20080009075A (ko) * | 2005-03-10 | 2008-01-24 | 씰 파마, 인크. | 영양 제제 |
| EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
-
2016
- 2016-12-13 MX MX2018008519A patent/MX2018008519A/es unknown
- 2016-12-13 BR BR112018011404A patent/BR112018011404A2/pt not_active IP Right Cessation
- 2016-12-13 WO PCT/EP2016/080796 patent/WO2017167420A1/en not_active Ceased
- 2016-12-13 SG SG11201803025VA patent/SG11201803025VA/en unknown
- 2016-12-13 CA CA3004046A patent/CA3004046A1/en not_active Abandoned
- 2016-12-13 CN CN201680072989.4A patent/CN108367009A/zh active Pending
-
2017
- 2017-03-30 EP EP17714730.3A patent/EP3436015A2/en not_active Withdrawn
- 2017-03-30 CN CN201780016224.3A patent/CN108778279A/zh active Pending
- 2017-03-30 CN CN202411049246.8A patent/CN118976042A/zh active Pending
- 2017-03-30 CA CA3240258A patent/CA3240258A1/en active Pending
- 2017-03-30 MX MX2018011334A patent/MX2018011334A/es unknown
- 2017-03-30 SG SG11201806547SA patent/SG11201806547SA/en unknown
- 2017-03-30 BR BR112018068369A patent/BR112018068369A2/pt not_active Application Discontinuation
- 2017-03-30 CN CN202411911916.2A patent/CN119679814A/zh active Pending
- 2017-03-30 CA CA3015434A patent/CA3015434C/en active Active
- 2017-03-30 EP EP21202009.3A patent/EP3984533A3/en active Pending
-
2018
- 2018-08-28 PH PH12018501830A patent/PH12018501830A1/en unknown
- 2018-09-18 MX MX2022014682A patent/MX2022014682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022014682A (es) | 2023-01-11 |
| BR112018011404A2 (pt) | 2018-12-04 |
| CN108367009A (zh) | 2018-08-03 |
| EP3984533A2 (en) | 2022-04-20 |
| EP3436015A2 (en) | 2019-02-06 |
| CA3004046A1 (en) | 2017-10-05 |
| CN118976042A (zh) | 2024-11-19 |
| CA3240258A1 (en) | 2017-10-05 |
| CA3015434A1 (en) | 2017-10-05 |
| PH12018501830A1 (en) | 2019-05-15 |
| SG11201806547SA (en) | 2018-10-30 |
| EP3984533A3 (en) | 2022-09-07 |
| WO2017167420A1 (en) | 2017-10-05 |
| SG11201803025VA (en) | 2018-05-30 |
| CN108778279A (zh) | 2018-11-09 |
| MX2018008519A (es) | 2018-08-16 |
| BR112018068369A2 (pt) | 2019-01-15 |
| CN119679814A (zh) | 2025-03-25 |
| CA3015434C (en) | 2024-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018011334A (es) | Composiciones y su uso. | |
| MX2018006291A (es) | Composiciones y su uso. | |
| CO2020002647A2 (es) | Composiciones de glp-1 y sus usos | |
| MX2022012236A (es) | Composiciones que comprenden colina y su uso. | |
| MX350588B (es) | Composiciones de alcanos semifluorados. | |
| SV2017005471A (es) | Derivados de quinazolina utilizados para tratar el vih | |
| CO2017012995A2 (es) | Derivados análogos de heteroarilos/arilo actvos como reguladores nrf2 y composiciones farmacéuticas de los mismos | |
| UY34742A (es) | Agentes para tratar trastornos que implican la modulación de receptores de rianodina | |
| MX2016004605A (es) | Formulaciones de anticuerpos estables acuosas. | |
| MX2017002667A (es) | Metodo para producir celulas progenitoras hepaticas adultas. | |
| MX2022014683A (es) | Composiciones que comprenden acidos grasos y su uso. | |
| MX2024010721A (es) | Formulaciones topicas que contienen ciclosporina y usos de las mismas. | |
| MX2022012237A (es) | Composiciones que comprenden fosfolipido y su uso. | |
| MX2017005243A (es) | Reducción de la viscosidad de formulaciones farmacéuticas. | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| UY34773A (es) | Ácidos indanoiloxidihidrobenzofuranilacéticos como moduladores de la actividad de gpr40, composiciones que los contienen y sus usos | |
| CR20160459A (es) | Nuevos derivados de piridina | |
| CR20160448A (es) | Nuevos derivados de piridina | |
| MX2016010131A (es) | Colores para antehogar libres de niquel y libres de cromo para tanques de vidrio. | |
| WO2017167898A3 (en) | Compositions comprising vitamins and their use | |
| CL2018001602A1 (es) | Composición nutricional y fórmula infantil para promover la mielinización del cerebro | |
| CL2020000528A1 (es) | Composiciones y uso para promover, apoyar u optimizar la mielinización de novo. (divisional solicitud 201801600) | |
| MX2018007468A (es) | Composiciones de colageno 7 y metodos para usar las mismas. | |
| CL2018001604A1 (es) | Composición nutricional y fórmula infantil para promover la mielinización del cerebro |